The development of CD4+ T effector cells during the type 2 immune response

被引:24
|
作者
Gause, WC [1 ]
Ekkens, M
Nguyen, D
Mitro, V
Liu, Q
Finkelman, FD
Greenwald, RJ
Urban, JF
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA
[2] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH USA
[3] USDA, Immunol Dis Resistance Lab, Inst Livestock & Poultry Sci, Beltsville, MD 20705 USA
关键词
CD4(+) T cell; costimulation; CD28; B7; type; 2; Th2; cytokines; immune response;
D O I
10.1007/BF02786507
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple pathways may be involved in the development of interleukin 4 (IL-4) producing T helper (Th) cells and the associated type 2 immune response. Increasing evidence suggests that the strength of signals delivered to the T cell may favor the development of the type 2 response. In contrast, antigen-presenting cell- (APC) derived stimuli produced following pattern recognition receptor binding during the innate response promotes the development of interferon-gamma (IFN-gamma) producing cells and the associated type 1 immune response. In many cases, the balance between increased signaling strength and the innate response may determine whether the type 2 response develops. T cell receptor (TCR), CD4, and costimulatory molecule interactions may all contribute to signal strength, but the type 2 immune response may be particularly dependent on the availability of coreceptor and costimulatory molecule interactions. B7 ligand interactions are required for the development of the type 2 immune response and interaction of CD28 with either B7-1 or B7-2 can provide sufficient signals for its initiation. In B7-2-deficient mice, the initial type 2 immune response is intact, but the response is not sustained, suggesting that B7-2 is important at later stages of the type 2 immune response. The roles of CD28 and CTLA-4 during the type 2 response remain unclear. The type 2 response to infectious pathogens is pronounced in CD28(-/-) mice, suggesting that. other costimulatory molecule interactions can substitute for CD28 for the development of IL-4 producing T cells and the associated type 2 immune response.
引用
收藏
页码:55 / 65
页数:11
相关论文
共 50 条
  • [1] The development of CD4+ T effector cells during the type 2 immune response
    William C. Gause
    Melinda Ekkens
    Diep Nguyen
    Velia Mitro
    Qian Liu
    Frederick D. Finkelman
    Rebecca J. Greenwald
    Joseph F. Urban
    Immunologic Research, 1999, 20 : 55 - 65
  • [2] The role of B cells in the development of CD4 effector T cells during a polarized th2 immune response
    Liu, Qian
    Liu, Zhugong
    Rozo, Cristina T.
    Hamed, Hossein A.
    Alem, Farhang
    Urban, Joseph F., Jr.
    Gause, William C.
    JOURNAL OF IMMUNOLOGY, 2007, 179 (06): : 3821 - 3830
  • [3] Development of CD4+ effector T cells and susceptibility to infectious diseases
    Locksley, RM
    Fowell, DJ
    Shinkai, K
    Wakil, AE
    Lacy, D
    Bix, M
    MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION VII: MOLECULAR DETERMINANTS OF MICROBIAL IMMUNITY, 1998, 452 : 45 - 52
  • [4] Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox
    Oh, David Y.
    Fong, Lawrence
    IMMUNITY, 2021, 54 (12) : 2701 - 2711
  • [5] Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice
    Drake, L. Y.
    Iijima, K.
    Kita, H.
    ALLERGY, 2014, 69 (10) : 1300 - 1307
  • [6] Heterogeneity of human effector CD4+ T cells
    Annunziato, Francesco
    Romagnani, Sergio
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (06)
  • [7] Primary antitumor immune response mediated by CD4+ T cells
    Corthay, A
    Skovseth, DK
    Lundin, KU
    Rosjo, E
    Omholt, H
    Hofgaard, PO
    Haraldsen, G
    Bogen, B
    IMMUNITY, 2005, 22 (03) : 371 - 383
  • [8] The central role of CD4+ T cells in the antitumor immune response
    Hung, K
    Hayashi, R
    Lafond-Walker, A
    Lowenstein, C
    Pardoll, D
    Levitsky, H
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (12): : 2357 - 2368
  • [9] Function and dysfunction of CD4+ T cells in the immune response to melanoma
    Fischer, WH
    Straten, PT
    Terheyden, P
    Becker, JC
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1999, 48 (07) : 363 - 370
  • [10] Function and dysfunction of CD4+ T cells in the immune response to melanoma
    Wolfgang H. Fischer
    Per thor Straten
    Patrick Terheyden
    Jürgen C. Becker
    Cancer Immunology, Immunotherapy, 1999, 48 : 363 - 370